Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) is partnering with a leading digital cannabis analytics company to place educational kiosks in each of its clinics to provide information, data and analysis of physician-recommended alternative CBD therapies.
Together with its partner, Cannvas MedTech Inc (CSE:MTEC) (OTCMTKS:CANVF), Empower is initiating a pilot program to launch a comprehensive education, data collection and analysis program that sees Cannvas kiosks installed in Empower’s medical clinics.
The new partnership comes as Empower repositions its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data-driven focus to improve patients' lives with products, technology and health systems, CEO Steven McAuley said in a statement.
“The addition of the Cannvas educational kiosks, a user friendly and highly interactive education platform, is a tremendous step forward to making our brand one of the go-to sources for content for both patients and the medical community nationwide,” he said.
Cannvas’ CEO Shawn Moniz said that the partnership represents an opportunity to bring unbiased cannabis education to a large population of patients looking for therapies to alleviate a number of ailments, while also learning more about what behaviours may drive the decision to look at cannabis as an alternative or complementary treatment.
Cannvas will be a key data and analytics partner for Empower by providing insights on customer behaviours and industry trends and integrating existing data partnerships.
Empower also plans to begin further pilot initiatives with Cannvas to provide content and educational links to Cannvas.me and Cannvas.health directly from the new Empower website www.empowerclinics.com and through its tele-medicine portal.
Shares of Empower closed Wednesday at C$0.17 in Canada and US$0.14 in the US, while Cannvas shares were at C$0.26 in Canada and US$0.19 in the US.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas